Apply for Support
Funding Opportunities Heading link
If you are interested in applying for support from UICentre, but are not sure where to start, we are glad to start a discussion with you! Please contact us at email@example.com to set up a Zoom call.
"Launch Seed Grant” Request for Applications (RFA) Heading link
Open to all UIC Faculty: Due September 15, 2023
UICentre is the campus-wide drug discovery enterprise of the University of Illinois Chicago (UIC). Our mission is to catalyze the formation of multidisciplinary teams of scientists and physicians, that collaborate to translate scientific discoveries and clinical observations into new therapies for areas of unmet medical need.
To form such multidisciplinary teams, UICentre offers seed funding through several mechanisms. The Launch Seed Grant mechanism is open to all UIC faculty, and seeks to fund projects focused on finding new drug-like small molecules, which can comprise robust assay development, high throughput screening (HTS), and/or hit-to-lead medicinal chemistry projects. Proposed target validation studies using synthetic chemical probes are also considered receptive to this RFA.
Funding via this mechanism can range from $10K- $50K for one year. Successful applications will present not only compelling preliminary data, but also provide a credible plan towards a specific milestone, that if achieved would position the project to receive external funding.
Faculty seeking support via this mechanism are asked to submit their applications to firstname.lastname@example.org by 5 pm September 15, 2023. Pre-submission inquiries can also be directed to email@example.com. The instructions for this RFA can be found here.
U2D2: University of Illinois Cancer Center-UICentre Drug Discovery Program Heading link
The application period for the 2nd RFA for the collaboration between the University of Illinois Cancer Center (UICC) and the UICentre (entitled U2D2) closed on 7/21/23. The next application deadline is likely to be in December 2023. Please contact firstname.lastname@example.org with any questions.